Albert Bourla is the chairman and chief executive officer of the American pharmaceutical corporation Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer’s divisions, including Zoetis, the Vaccines, Oncology and Consumer Healthcare business. Bourla was born and raised in Thessaloniki, Greece.
About Albert Bourla in brief
Albert Bourla is the chairman and chief executive officer of the American pharmaceutical corporation Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer’s divisions, including Zoetis, the Vaccines, Oncology and Consumer Healthcare business, and Pfizer Innovative Health. Bourla was born and raised in Thessaloniki, Greece. He left Greece with his wife when he was 34 and since then he has lived in seven different cities, in four different countries. In April 2019, he was presented with the award for \”Preeminent Greek Leader\” of the global pharmaceutical industry by Geoffrey R.
Pyatt, in his role as United States Ambassador to Greece, at the Prix Galien Greece Awards ceremony. In January 2020, Bourla assumed the additional post of executive chairman, upon Pfizer’s announcement in late 2019 that Ian Read would retire from the position after eight years. In November 2020, after the Pfizer vaccine’s trial success communication, he sold USD 5m of his Pfizer shares after the share price had risen by 7%.
You want to know more about Albert Bourla?
This page is based on the article Albert Bourla published in Wikipedia (as of Dec. 07, 2020) and was automatically summarized using artificial intelligence.
